Officials to push back implementation of new Basel regime until 2027 as they await clarity on US approach
Plus, Goldman chief cautions start-ups on going public and a dispatch from JPMorgan’s healthcare deals conference
The political backlash against ESG has intensified — but the sector is evolving
Buying frenzy peaked at end of year spurred by Donald Trump’s presidential victory
Firms intended to backstop frontline insurers raised rates and increased recovery thresholds after losses on prior blazes